Psychiatric Times Vol 36, Issue 10

Mania and Hypomania: The Latest Thinking on Duration of Episodes and Other Features

October 29, 2019

An international task force of experts in the diagnosis and treatment of bipolar disorder was recently convened to address concerns about DSM-5 criteria, particularly the definitions of manic episodes. The DSM’s duration criteria is an area of concern.

Complementary and Alternative Treatments for ADHD: What the Evidence Suggests

October 15, 2019

Recent surveys suggest that 7% to 8% of children and 4% to 5% of adults meet ADHD criteria. This CME article provide an understanding of the evidence for the use of complementary and alternative (CAM) treatments for ADHD.

The Opioid Epidemic Settlements: Who Will Benefit?

October 10, 2019

Judgements and settlements are starting in Oklahoma against various pharmaceutical companies for their alleged roles in that state’s opioid crisis. Who would be the beneficiaries of these funds?

Brain Glucose, Insulin Resistance, and Memory in Schizophrenia

October 08, 2019

Memory impairments have been shown to compromise quality of life in patients with schizophrenia. Findings from a recent study show that insulin resistance may be an underlying cause of memory loss in this population.

Conversations in Critical Psychiatry: Allen Frances, MD

May 23, 2019

A series aimed at engaging prominent individuals who have made meaningful criticisms of psychiatry and have offered constructive alternative perspectives. First interview: Allen Frances, MD, Chair of the DSM-IV Task Force.